Skip to main content
. 2020 Jun 28;13(6):969–980. doi: 10.1093/ckj/sfaa049

FIGURE 2.

FIGURE 2

Summary of pharmacokinetic studies showing serum drug levels, serum half-lives from systemically and intravitreally injected VEGF inhibitors. [Drug], concentration of drug every 2 weeks; mg, milligrams; mg/kg, milligram/kilogram; OD, right eye; OU, left eye; q(x) weeks, every (x) weeks; s[Drug], serum concentration of drug; T1/2, half-life (in days).